Optimizing CRISPR/Cas9 genome editing in primary human hematopoietic cells to advance studies into HIV biology
Hong‐Ru Chen, Nicole P. Kadzioch, Madeleine Gapp, Hsiu-Hui Yang, Adrian Ruhle, Javier M. Villamizar, Thimo Fuchs, Niklas Arndt Schmacke, Veit Hornung, Roberto F. Speck, Oliver Till Keppler, Manuel Albanese
This study develops a CRISPR/Cas9 platform for editing primary human HSPCs to investigate HIV host factors and their impact on viral infection in vitro and in vivo.
bioRxiv · Aug 5, 2026 · PreprintBioengineering